Application of lipid-based formulations in drug discovery.

[1]  M. Tomita,et al.  The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs. , 2005, Drug metabolism and pharmacokinetics.

[2]  S. Gad,et al.  Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species , 2006, International journal of toxicology.

[3]  V. Stella,et al.  Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules , 1986 .

[4]  Bradley D Anderson,et al.  What determines drug solubility in lipid vehicles: is it predictable? , 2008, Advanced drug delivery reviews.

[5]  O. Hernell,et al.  Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. , 1990, Biochemistry.

[6]  Ping Gao,et al.  Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations , 2004, Drug development and industrial pharmacy.

[7]  Christopher J H Porter,et al.  Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products , 2002, The Journal of pharmacy and pharmacology.

[8]  S. Yuk,et al.  Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. , 2004, International journal of pharmaceutics.

[9]  G. Edwards,et al.  A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine. , 2001, Journal of pharmaceutical sciences.

[10]  G. Edwards,et al.  Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs , 2007, Pharmaceutical Research.

[11]  W. Charman,et al.  Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. , 2000, Journal of pharmaceutical sciences.

[12]  Ben J. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.

[13]  D. Hauss.  Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.

[14]  W. Charman,et al.  Lipid-based vehicles for the oral delivery of poorly water soluble drugs , 1997 .

[15]  Christopher J H Porter,et al.  Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update☆ , 2007, Advanced Drug Delivery Reviews.

[16]  A. Serajuddin,et al.  Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. , 2005, International journal of pharmaceutics.

[17]  Bradley D. Anderson,et al.  Quantitative Solubility Relationships and the Effect of Water Uptake in Triglyceride/Monoglyceride Microemulsions , 2008, Pharmaceutical Research.

[18]  S. Benita,et al.  Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  D. Craig,et al.  The development and characterisation of triglyceride-based 'spontaneous' multiple emulsions. , 2005, International journal of pharmaceutics.

[20]  Georges Houin,et al.  Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. , 2004, International journal of pharmaceutics.

[21]  S. Benita,et al.  Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  Bradley D Anderson,et al.  Predictive relationships for the effects of triglyceride ester concentration and water uptake on solubility and partitioning of small molecules into lipid vehicles. , 2004, Journal of pharmaceutical sciences.

[23]  Christopher J H Porter,et al.  Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. , 2008, Advanced drug delivery reviews.

[24]  G. Edwards,et al.  Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. , 2004, Journal of pharmaceutical sciences.

[25]  D. Craig,et al.  The emulsification and solubilisation properties of polyglycolysed oils in self‐emulsifying formulations , 2004, The Journal of pharmacy and pharmacology.

[26]  V. Jannin,et al.  Approaches for the development of solid and semi-solid lipid-based formulations. , 2008, Advanced drug delivery reviews.

[27]  S. Benita,et al.  Enhanced Oral Absorption of Paclitaxel in a Novel Self-Microemulsifying Drug Delivery System with or Without Concomitant Use of P-Glycoprotein Inhibitors , 2004, Pharmaceutical Research.

[28]  Seshadri Neervannan,et al.  Preclinical formulations for discovery and toxicology: physicochemical challenges , 2006, Expert opinion on drug metabolism & toxicology.

[29]  A. Thomson,et al.  Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. , 1993, Canadian journal of physiology and pharmacology.

[30]  O. Hernell,et al.  Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. , 1990, Biochemistry.

[31]  A. Müllertz,et al.  Bioavailability of Seocalcitol IV: Evaluation of Lymphatic Transport in Conscious Rats , 2006, Pharmaceutical Research.

[32]  C. Porter,et al.  Intestinal lymphatic drug transport: an update. , 2001, Advanced drug delivery reviews.

[33]  D. Dean,et al.  Pharmacokinetics, Metabolism, and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Rats and Rhesus Monkeys , 2010, Drug Metabolism and Disposition.

[34]  C. Porter,et al.  In vitro assessment of oral lipid based formulations. , 2001, Advanced drug delivery reviews.

[35]  P. Tso,et al.  An examination of the factors affecting intestinal lymphatic transport of dietary lipids. , 2001, Advanced drug delivery reviews.

[36]  Chong-K. Kim,et al.  Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  Gérard Hopfgartner,et al.  P‐Glycoprotein and Surfactants: Effect on Intestinal Talinolol Absorption , 2005, Clinical pharmacology and therapeutics.

[38]  F. Poelma,et al.  Intestinal Absorption of Drugs. III. The Influence of Taurocholate on the Disappearance Kinetics of Hydrophilic and Lipophilic Drugs from the Small Intestine of the Rat , 1990, Pharmaceutical Research.

[39]  A. Hoffman,et al.  Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats , 2006, Pharmaceutical Research.

[40]  C. O’Driscoll.  Lipid-based formulations for intestinal lymphatic delivery. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  David M. Shackleford,et al.  Contribution of Lymphatically Transported Testosterone Undecanoate to the Systemic Exposure of Testosterone after Oral Administration of Two Andriol Formulations in Conscious Lymph Duct-Cannulated Dogs , 2003, Journal of Pharmacology and Experimental Therapeutics.

[42]  P. Gao,et al.  Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. , 2003, Journal of pharmaceutical sciences.

[43]  G. Edwards,et al.  Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. , 2008, Journal of pharmaceutical sciences.

[44]  J. S. Pedersen,et al.  Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. , 2007, Journal of pharmaceutical sciences.

[45]  Ben J Boyd,et al.  Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. , 2004, Journal of pharmaceutical sciences.

[46]  P. Constantinides,et al.  Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies. , 2007, Journal of pharmaceutical sciences.

[47]  B. Boyd,et al.  Examination of the impact of a range of Pluronic surfactants on the in‐vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone , 2006, The Journal of pharmacy and pharmacology.

[48]  G. Edwards,et al.  Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[49]  B. Griffin,et al.  Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. , 2008, Advanced drug delivery reviews.

[50]  Colin W. Pouton,et al.  Formulation of self-emulsifying drug delivery systems , 1997 .

[51]  V. Stella,et al.  An experimental system designed to study the in situ intestinal lymphatic transport of lipophilic drugs in anesthetized rats , 1986 .

[52]  S. Ozkan,et al.  Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[53]  B. Griffin,et al.  A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid‐based formulations in the anaesthetised rat model , 2006, The Journal of pharmacy and pharmacology.

[54]  A. Date,et al.  Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. , 2007, International journal of pharmaceutics.

[55]  C. Pouton,et al.  Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.

[56]  C. Porter,et al.  Lipophilic prodrugs designed for intestinal lymphatic transport , 1996 .

[57]  D. Putnam,et al.  Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process. , 2004, Journal of pharmaceutical sciences.

[58]  B. Boyd,et al.  Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. , 2003, Journal of pharmaceutical sciences.

[59]  J. DeSesso,et al.  Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[60]  M. Carvajal,et al.  Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs , 1994 .

[61]  Ben J. Boyd,et al.  Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation , 2004, Pharmaceutical Research.

[62]  M. Khan,et al.  Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. , 2001, International journal of pharmaceutics.

[63]  Arik Dahan,et al.  The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[64]  J. Dressman,et al.  Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[65]  S. Murdande,et al.  Development of a self-emulsifying formulation that reduces the food effect for torcetrapib. , 2008, International journal of pharmaceutics.

[66]  E. Wasan,et al.  Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections. , 2008, Advanced drug delivery reviews.

[67]  P. Constantinides,et al.  Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects , 1995, Pharmaceutical Research.

[68]  J. Patton,et al.  Watching fat digestion. , 1979, Science.

[69]  C. Pouton,et al.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[70]  C. Price,et al.  Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. , 1998, Journal of pharmaceutical sciences.

[71]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[72]  Anette Müllertz,et al.  Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats--effect of medium and long chain triglycerides. , 2005, Journal of pharmaceutical sciences.

[73]  Christopher J. H. Porter,et al.  Intestinal Lymphatic Transport of Halofantrine Occurs After Oral Administration of a Unit-Dose Lipid-Based Formulation to Fasted Dogs , 2003, Pharmaceutical Research.

[74]  C. Porter,et al.  Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. , 2000, Journal of pharmaceutical sciences.

[75]  Colin W Pouton,et al.  Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.